Cynthia Tracy Recognized for Work to Update Atrial Fibrillation Guidelines for the ACC and AHA

Dr. Cynthia Tracy posing for a portrait

Cynthia Tracy, M.D., director of electrophysiology, associate director of cardiology, and professor of medicine at the George Washington University School of Medicine and Health Sciences, was recently recognized by the American College of Cardiology (ACC) and the American Heart Association (AHA) for her contribution to the 2014 Guideline for the Management of Patients with Atrial Fibrillation.

The ACC/AHA clinical practice guidelines serve to provide evidence-based guidance to physicians and other health care providers practicing cardiovascular medicine. Moreover, these guidelines can provide a foundation for other applications, such as performance measures, appropriate use criteria, and both quality improvement and clinical decision support tools.

Tracy was chosen for this initiative to provide her expertise and leadership at a national level. Her service to the cardiology community at large, as well as exceptional academic citizenship was recognized as highly valued by the ACC and AHA. These guidelines will have important benefits to cardiovascular health care professionals and patients.

The updated guidelines have been jointly published in the Journal of the American College of Cardiology and Circulation.

Latest News

The George Washington University School of Medicine and Health Sciences recently welcomed the Fall 2025 cohort of the Integrated Biomedical Sciences (IBS) PhD Program, marking the program’s 30th class of doctoral students.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the appointment of Brandon Beattie, MMSc, PA-C, assistant professor of Physician Assistant (PA) studies, to serve as the director of the PA Program.
A growing cadre of GW SMHS clinicians who are translating frontline frustrations into real-world solutions. Investigators across the school are leveraging GW’s innovation ecosystem to bring new technologies from concept to commercialization, improving the lives of patients far beyond Foggy Bottom.